Prevalence and clinical significance of collateral findings detected by chest computed tomography in patients undergoing atrial fibrillation ablation by M. Casella et al.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CLINICAL RESEARCH
Ablation for Atrial Fibrillation
Prevalence and clinical significance of collateral
findings detected by chest computed tomography
in patients undergoing atrial fibrillation ablation
Michela Casella1*, Francesco Perna2, Gianluca Pontone1, Antonio Dello Russo1,
Daniele Andreini1, Gemma Pelargonio2, Stefania Riva1, Gaetano Fassini1,
Mauro Pepi1, Giovanni Ballerini1, Massimo Moltrasio1, Benedetta Majocchi1,
Stefano Bartoletti1, Alberto Formenti1, Pasquale Santangeli3, Luigi Di Biase3,
Andrea Natale3, and Claudio Tondo1
1Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino IRCCS, Milan, Italy; 2Catholic University of the Sacred Heart, Rome, Italy; and 3Texas Cardiac Arrhythmia
Institute at St David’s Medical Center, Austin, TX, USA
Received 20 June 2011; accepted after revision 17 August 2011; online publish-ahead-of-print 20 September 2011
Aims Chest computed tomography (CT) scanning is increasingly used as an imaging technique in patients undergoing atrial
fibrillation (AF) catheter ablation. Chest CT scans visualize organs other than the heart and collateral findings may be
identified incidentally. Our study aims to assess the prevalence and clinical relevance of such collateral findings in
patients undergoing AF ablation.
Methods
and results
One hundred and seventy-three patients (127 males, age 59+10 years) underwent chest CT scan for image inte-
gration in AF ablation. Collateral findings from visualized thoracic and upper abdominal organs were collected. Find-
ings that required further investigations or treatment according to current guidelines were considered as clinically
significant. A total of 164 collateral findings were identified in 97 (56%) patients, and most patients showed abnorm-
alities of the lungs (67 patients, 39%). Forty-nine (28%) patients had clinically significant findings needing further inves-
tigation and 17 (10%) of them required specific treatments, including three cases (1.7 %) of lung malignancy.
Conclusions Chest CT images acquired for integration in AF ablation should be read thoroughly as they may serve as a screening
tool for otherwise unrecognized clinically significant conditions of the heart, lungs, or other visualized organs.
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Introduction
Atrial fibrillation (AF) is the most common clinically significant
cardiac arrhythmia; it carries significant morbidity and mortality,
and directs the allocation of sizeable health care resources.1
According to the current ACCF/AHA/HRS guidelines for AF man-
agement,2 catheter ablation is increasingly used as a therapeutic
approach in patients with symptomatic drug-refractory AF.
Atrial fibrillation catheter ablation has undergone considerable
technical evolution over the past decade.3,4 The integration of
three-dimensional (3D) electroanatomical mapping systems with
pre-acquired images of cardiac anatomy is recognized as a major
advancement in the AF ablation technique.5
Both computed tomography (CT) and magnetic resonance
imaging (MRI) have been employed in this context,6 as they
provide an accurate imaging of pulmonary vein (PV) and left
atrial (LA) anatomy with excellent spatial resolution, supplying
the necessary anatomic information for successful ablation.
In comparing these techniques, it should be emphasized that
multi-slice CT angiography has become a standard non-invasive
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imaging technique to visualize vascular and cardiac anatomy.7
Moreover, CT is surely more widely available than MRI and is pre-
ferred in the evaluation of such structures as the pulmonary par-
enchyma, mediastinum, and upper abdomen.
The growing number of chest CT scans performed to diagnose
coronary artery disease has led to a steep increase in the identifi-
cation of so-called incidental or collateral findings,8– 15 broadly
defined as any finding that is unsuspected or unrelated to the clini-
cal indication for imaging. Some of these findings may explain
elements of the patient’s clinical presentation, whereas others
may reveal subclinical malignant disease, or even remain indetermi-
nate and require further investigation or follow-up.
To date, no systematic data have been published on the preva-
lence and clinical implications of collateral findings in patients
undergoing contrast-enhanced chest CT scan for image integration
with electroanatomical mapping in view of an AF catheter ablation
procedure. The aim of our study is to assess the prevalence and
distribution of clinically significant collateral findings in such
patients and to evaluate the impact of those findings on the
further clinical management and prognosis of the study population.
Methods
Study population
We enrolled 173 consecutive patients in apparently good health
except for AF, who were referred to the Centro Cardiologico
Monzino (Milan, Italy) between November 2009 and June 2010 to
undergo catheter ablation of AF. All patients had symptomatic
documented AF which had proven refractory to at least two
anti-arrhythmic drugs. With the intent of estimating the risk for
bronchogenic carcinoma, particular attention has been paid to ciga-
rette smoking habit. We defined as ‘former smokers’ patients who
had quit smoking .5 years before the date of enrolment.
Within 24 h prior to the ablation procedure, all patients underwent
a transoesophageal echocardiogram to rule out the presence of
thrombi in the LA or left atrial appendage (LAA) and a chest CT
scan to allow image integration for AF ablation. All patients had pro-
vided written informed consent to transoesophageal echocardiogram,
contrast-enhanced CT scan, and AF catheter ablation.
Computed tomography scan
Data acquisition
Chest CT angiography scans were acquired using a 64-slice multi-
detector CT scanner (GE-Lightspeed, General Electric, Milwaukee,
WI, USA), with a field of view (FOV) which extended in the z-axis
from the level of the carina to the diaphragmatic domes. A systematic
search of any collateral finding was performed in the FOV. Since a
consistent proportion of the patients were in AF at the moment of
the exam, CT scan was not synchronized with electrocardiogram
(ECG). It was acquired with a slice thickness of 0.625 mm and a slice
interval of 0.625 mm. Contrast medium administration consisted of
80–100 mL of 400 mgI/mL agent (Iomeron, Bracco, Milan, Italy)
injected through the antecubital vein at 5 mL/s followed by 60 mL of
saline chaser using a dual-syringe automatic injector (Stellant,
MedRad, Pittsburg, PA, USA). Scan synchronization with contrast
material was performed with the bolus tracking technique (SMART
PREP, GE, Milwaukee, WI, USA).
Image analysis
All images were transferred to an Advantage Windows workstation (GE
Healthcare, Milwaukee, WI, USA) and reviewed by two experienced
radiologists. Images were displayed in the original two-dimensional
(2D) format in the mediastinal windows (400 W/48C) and in the 3D
or 2D multi-planar reconstruction views. Computed tomography data
were recorded onto a CD-ROM in a Digital Imaging and COmmuni-
cations in Medicine (DICOM) format, using a soft tissue algorithm.
A first dataset was reconstructed with a small FOV tightly confined
around the heart. Thus, images from the contrast-enhanced CT angio-
graphy scan were analysed to answer the clinical issue, that is, to evalu-
ate the LA–PV anatomy. A second dataset was then reconstructed
with a larger FOV (from the level of the carina through the diaphrag-
matic domes) and the whole CT scan was analysed to search for
cardiac and extra-cardiac abnormalities, such as undetermined
nodules, suspected tumours, inflammatory diseases, infections, degen-
erative, and vascular lesions in the pulmonary parenchyma, mediasti-
num, breasts, or in the upper abdomen. The presence of collateral
findings was investigated by the two radiologists through the original
2D axial images displayed in the mediastinal windows (400 W/48C),
lung windows (1700 W/–508C), bone windows (2500 W/508C), and
liver windows (200 W/108C).
Analysis and management of collateral
findings
Collateral findings were identified in the chest and upper abdomen.
We defined as clinically significant all lesions deemed to require any
further medical investigation or follow-up according to current guide-
lines and consensus papers,16 –18 along with findings that were judged
to be important to recognize (such as vascular abnormalities). Non-
pulmonary collateral findings were followed up, if indicated, with the
appropriate first-line methods, such as ultrasound for kidney and
liver lesions, mammography or ultrasound for breast nodules, echocar-
diography for pericardial effusions, CT angiography for thoracic aortic
aneurysms, and so on.
Regarding pulmonary parenchymal lesions, we followed the rec-
ommendations from the Fleishner Society16 to establish if any
further investigation was required. In particular, if no previous
studies existed to document 2-year stability, a single follow-up chest
CT scan was performed at 12 months for lesions ,4 mm in diameter
only in high-risk subjects (patients with smoking history, previous
cancer, first-degree relatives with history of cancer, or other known
risk factors). Nodules .8 mm in size were followed up with CT
scan at 3, 9, and 24 months, or other investigations were performed
if appropriate, such as positron-emission tomography (PET), PET-CT,
bronchoscopy, or biopsy. Nodules in the 5–8 mm range were
managed according to their morphology and patient risk factors, as
stated by current guidelines.16 Moreover, features characteristically
associated with benign nodules, such as fat attenuation and diffuse,
central, or lamellated calcifications, were also taken into account in
order to spare the patient unnecessary radiation exposure from mul-
tiple follow-up studies.
Statistical analysis
All variables are reported as mean+ standard deviation. Continuous
variables were compared with either Student’s t-test or the Wilcoxon
rank-sum test. Qualitative variables are presented as numbers and pro-
portions and were compared using Fisher’s exact test. All P values
were two sided, and statistical significance was established at P, 0.05.
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Results
Study population
Table 1 lists the demographic and clinical features of the 173 con-
secutive patients we enrolled (127 males; mean age 59+10
years). Of these, 112 (65%) had paroxysmal AF, while 61 (35%)
had long-standing/persistent AF. At the time of the procedure,
19 (11%) patients were active smokers, 67 (39%) were former
smokers, and the remaining 87 (50.3%) patients were
non-smokers.
Collateral findings and their impact
All patients successfully underwent contrast-enhanced CT scan
without complications. We detected 164 collateral findings in 97
patients (56%). The mean follow-up of the study was 17+5
months. We identified as clinically significant 72 findings in 57
patients (33% of the total population, 59% of the population
with collateral findings); of the 173 patients, 49 patients (28%)
underwent further investigations and in 17 (10%) this led to thera-
peutic decisions. Diagnostic work-up included 50 CT scans, 16
ultrasound studies, 3 conventional radiographs, 3 mammographies,
4 MRI studies, 7 PET-CT scans, 5 bronchoscopies with transbron-
chial biopsy, and 10 provocative cardiac exercise tests. Table 2 pre-
sents the location of incidental findings and Table 3 summarizes
clinically significant findings with the additional work-up and thera-
peutic consequences they implied.
The additional time spent by the radiologists for the study of
collateral findings consisted of a mean of 7+ 3 min: 2+1 min
were needed to reconstruct the second dataset of the chest CT
with a larger FOV, while 5+ 2 min were involved in reading the
whole CT to look for all the collateral findings.
On the basis of CT findings, we decided not to proceed with AF
ablation in one patient due to a diagnosis of lung cancer, in one
patient with inter-atrial shunt, and in six patients due to pneumo-
nia. The procedure was instead merely postponed during the same
hospital stay in 10 patients who required provocative tests for sus-
pected myocardial ischaemia. All other patients (90%) underwent a
successful AF catheter ablation at the scheduled time.
Pulmonary collateral findings
Pulmonary abnormalities were found in 67 of 173 patients (39%);
39 (58%) lesions were identified as clinically significant. These
included six patients with pneumonic consolidations requiring anti-
biotics and follow-up with CT or chest X-rays.
A nodule .8 mm in size was found in three patients, in two of
whom further investigations (PET-CT, follow-up CT) showed sub-
stantial 2-year stability and ruled out malignancy. In the remaining
one patient (0.6%), however, the nodule was accompanied by sat-
ellite lymphadenopathy and PET-CT, bronchoscopy, and biopsy led
to a diagnosis of bronchogenic carcinoma (T1N2M0), which was
treated surgically (Figure 1).
A total of 26 nodules ranging 5–8 mm in size were found in 23
patients (13%). Of these, 8 patients required no further investi-
gation (3 because of previously documented 2-year stability,
Table 1 Demographic and clinical characteristics of
the patient population
Patients 173 (100)
Age (years) 59 + 10
Male gender 127 (74%)
Arterial hypertension 84 (49%)
Diabetes mellitus 7 (4%)
Smokers, current 19 (11%)
Smokers, former 67 (39%)
Atrial fibrillation, paroxysmal 112 (65%)
Atrial fibrillation, persistent/long-standing 61 (35%)
Values are n (%) or mean+ standard deviation.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Organs and structures with collateral findings
Organ/
apparatus
Structure Findings n
Cardiovascular
system
Pericardium Effusion 3
Coronary
arteries
Calcifications 10
Thoracic
aorta
Dilatation 4
Inter-atrial
septum
Inter-atrial shunt and
pulmonary vein
anomalous connection
1
Great vessels Common origin of
brachiocephalic trunk
and left common carotid
artery
1
Lung Nodules≤4 mm 29
Nodules 5–8 mm 26
Nodules .8 mm 3
Emphysema/bullae 3
Hamartomas 3
Atelectasis 2
Inflammatory
consolidations
4
Airways Bronchi Bronchiectasis 4
Pleura Focal thickening 6
Mediastinum Lymph
nodes
Swelling 23
Thymus Thymic remnants 3
Breast Nodules 3
Spinal column Vertebral fracture 4
Haemangiomas 1
Osteoarthritis 4
Abdomen Liver Steatosis 5
Cysts 5
Haemangiomas 3
Focal lesions 3
Parenchymal calcifications 2
Kidney Cysts 5
Gall bladder Cholelithiasis 3
Spleen Calcifications 1
Total 164
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5 because of a benign pattern of calcification), while in the other 15
follow-up CT showed nodule stability in 9 patients and nodule
change in 6 patients. Of these six, in two patients a diagnosis of
pneumonia was established because of nodule growth, develop-
ment of new densities, and air bronchogram sign; the remaining
four underwent PET-CT and bronchoscopy-guided biopsy, so
that bronchogenic carcinoma was ruled out in two patients and
confirmed by subsequent surgery in the last two.
Nodules ≤4 mm in size were considered as clinically significant in
four patients with a history of smoking; of these, two required no
further investigation because of previously documented 2-year stab-
ility, while in the other two follow-up CT showed nodule stability too.
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Table 3 Clinically significant collateral findings and their diagnostic/therapeutic consequences
Clinically significant collateral
findings
n Findings needing
investigations
Type of investigation Findings needing
treatment
Treatment
description
Pericardial effusions 3 3 Ultrasound 4 Anti-inflammatory
drugs
Coronary calcifications 10 10 Exercise testing 0
Thoracic aorta dilation 2 2 CT 0
Inter-atrial shunt and pulmonary vein
anomalous connection
1 0 1 Cardiac surgery
Common origin of brachiocephalic trunk
and left common carotid artery
1 0 0
Pulmonary nodules≤4 mm 4 2 CT 0
Pulmonary nodules 5–8 mm 26 15 CT, PET-CT,
bronchoscopy, biopsy
2 Surgical excision
2 Antibiotic therapy
Pulmonary nodules .8 mm 3 3 CT, PET-CT,
bronchoscopy, biopsy
1 Surgical excision
Pulmonary inflammatory consolidations 6 6 CT, chest X-rays 6 Antibiotic therapy
Hepatic cysts 2 2 Ultrasound 0
Hepatic haemangiomas 3 3 Ultrasound 0
Hepatic focal lesions 3 3 Ultrasound 0
Hepatic calcifications 1 1 Ultrasound 0
Breast nodules 3 3 Mammography,
ultrasound
0
Vertebral fractures 4 4 MRI 2 Orthopaedic corset
Total 72 58 17
Figure 1 Computed tomography axial windows lung image (A) showed irregular, speculated solitary pulmonary nodule (size 9 mm) with
central cavitation in the right lower lobe (yellow arrow). The mediastinum windows image (B) confirmed the presence of central cavitation.
These findings are suspected for malignant nature of the nodule. Three-month follow-up showed the nodule growing and computed
tomography-positron-emission tomography confirmed later the malignant nature of the lesion.
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A total of five lung nodules (three in the 5–8 mm range, two in
the ≤ 4 mm in size) were detected in five patients who already had
such lesions documented at previous CT studies; in these patients,
the chest CT performed for AF ablation allowed us to establish
2-year stability of the nodules and was considered as a follow-up
CT, thus sparing the patients further investigations.
Taking smoking habit into consideration, 42 of 58 (72%) nodules
were detected in smokers or former smokers and 16 of 58 (28%)
in non-smoking patients (P ¼ 0.01). Nodules that required
follow-up because they were ≥5 mm in size were also significantly
more frequent in smokers or former smokers (22 of 29, 76%)
compared with non-smokers (7 of 29, 24%) (P ≤ 0.001).
Extra-pulmonary thoracic collateral
findings
Extra-pulmonary thoracic collateral findings were observed in 21
of 173 patients (12%) and were all judged as not clinically signifi-
cant. They included 6 cases of focal pleural thickening, 4 bronchiec-
tasis, 3 thymic remnants, and 26 swollen lymph nodes, all of which
were calcified and ,1 cm in diameter.
Breast collateral findings
In three women (7% of the female study population) breast
nodules were detected, none of which showed signs of malignancy
on mammography and ultrasound. These women continued their
follow-up in specialized centres.
Cardiovascular collateral findings
Cardiovascular collateral findings were observed in 19 of 173
patients (11%). Evaluation of coronary anatomy requires ECG syn-
chronization and was therefore possible only in 106 patients (61%)
who were in sinus rhythm at the time of CT. In 10 patients CT
showed coronary calcification of one or two arteries; all patients
underwent a provocative exercise test that excluded
stress-induced myocardial ischaemia. Four patients had a dilated
thoracic aorta: in two cases the diameter was ,4 cm, and no
further investigation was deemed necessary, whereas in the
other two it was still ,5.5 cm and stable on follow-up CT angio-
graphy, so that there was no indication to surgery. Three pericar-
dial effusions were treated with anti-inflammatory drugs and
shown to have regressed on follow-up echocardiography. A case
of inter-atrial shunt and anomalous connection of right superior
PV into right atrium was detected; this patient required surgery
correction (Figure 2). A common origin of the brachiocephalic
trunk and left common carotid artery was also detected. Cardiac
or aortic features that had already been observed by transoeso-
phageal echocardiogram were not considered as CT incidental
collateral findings.
Abdominal collateral findings
Abdominal collateral findings were observed in 27 of 173 patients
(16%). The most frequent were liver abnormalities: focal lesions in
three patients, haemangioma in three, cysts in five, steatosis in five,
and parenchymal calcification in two (Figure 3). Nine of these find-
ings required further evaluation with ultrasound. In the three
patients with focal lesions ultrasound examination confirmed the
lesions as cysts in two patients and as haemangioma in one case.
Haemangioma and cysts detected on CT were confirmed by ultra-
sound. A parenchymal calcification was eventually found to be a
haemangioma. All other hepatic lesions, as well as the incidental
findings identified in abdominal organs other than the liver, were
not clinically significant.
Spinal column collateral findings
Spinal column lesions were discovered in 9 of 173 patients (5%).
Of these, four were vertebral fractures, which STIR MRI sequences
identified as chronic in two cases (requiring no further action) and
recent in the other two. The latter were treated with orthopaedic
corset for fracture stabilization.
Discussion
The main result of our study is that contrast-enhanced chest CT
imaging allowed detecting clinically significant collateral findings in
Figure 2 Computed tomography volume rendering reconstruction (A) of left atrium, pulmonary veins, and superior vena cava, showing the
presence of inter-atrial shunt and anomalous connection of right superior pulmonary vein into right atrium. Multi-planar reconstruction
(B) confirmed the presence of inter-atrial shunt consistent with venous sinus atrial septal defect and the anomalous connection of superior
pulmonary vein into right atrium close to the superior vena cava ostium. ASD, atrial septal defect; LA, left atrium; RA, right atrium.
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about one-third of patients in ‘apparently’ good health. Of note, in
1.7% of cases, the detection of a collateral finding allowed early
diagnosis and treatment of a potentially life-threatening condition
such as lung cancer.
Computed tomography studies of the heart are being per-
formed with increasing frequency as the preferred imaging
method to plan and perform AF catheter ablation,5,6,19 but while
this entails irradiation of almost the entire chest, only a small
FOV focused on the heart is routinely analysed in some detail.
However, a larger FOV can be reconstructed from the raw data
subjecting the patient to no additional radiation; in this way
plenty of information on the pulmonary parenchyma, mediastinum,
breasts, spine, and upper abdomen becomes available. A crucial
element is the likelihood of collateral findings in these organs
and controversies abound as to whether the lungs and chest
should be formally reviewed.20,21
Several studies elucidated the prevalence of non-cardiac
abnormalities in cardiac CT studies, almost exclusively performed
for the diagnosis of coronary artery disease.8 –15 Recently, Cade-
martiri et al.22 in a population of 670 patients undergoing CT
scan for suspected coronary artery disease, described collateral
findings in 79.4% of patients. Among these findings, 26.9% were
classified as non-significant, 66.5% as mild, and 6.6% as compulsory
for study; in 12.1% of patients’ non-cardiac findings required
additional clinical or radiological follow-up. In an another study,
Onuma et al.9 reported that 23% of patients had extra-cardiac
disease requiring additional work-up, and four cases (0.8%) of
malignancy were revealed. Similar previously published studies
were carried out on electron beam CT examinations. Horton et
al.23 reviewed the scans performed with a small FOV including
just a portion of the chest, therefore resulting in a 7.8% rate
only of significant findings. In another study by Hunold et al.24
53% of the study subjects had extra-coronary abnormal findings,
but analysis was limited to the mediastinal windows, therefore dis-
carding any possible evidence on pulmonary parenchymal nodules.
In summary, the proportion of patients with at least one imaging
abnormality requiring further investigation or follow-up varies
widely among different studies, but, rather homogeneously,
almost half of all collateral findings consisted of suspect pulmonary
nodules. Malignancy is revealed in a percentage ranging from 0.2 to
1% of patients.10,22
These data are corroborated by our study: over a 17+ 5 month
follow-up we investigated 173 patients, of whom 94 showed collat-
eral findings. Thirty-three per cent of the patients had clinically sig-
nificant findings, often needing additional work-up and, in three
patients, previously undiscovered early-stage bronchogenic carci-
noma was diagnosed. In comparison with the relevant literature,
in our population a higher incidence (1.7%) of malignancy was
observed. This feature is particularly significant if we consider
that such an incidental finding has been reported to improve the
10-year survival rate in the 2006 paper by the Early Lung Cancer
Action Program Investigators dealing with patients with stage I
lung cancer detected on CT screening.25 The higher prevalence
of malignancy in our population is probably due to a systematic
analysis of almost all pulmonary parenchyma, including lateral
lung fields, which are often excluded from routine cardiac CT
scanning.
We discovered no case of ischaemic heart disease in our study,
even though it is well known that AF is associated with various car-
diovascular diseases, including coronary artery disease.4 While we
observed 10 cases of significant coronary calcifications on CT, a
provocative exercise test excluded inducible myocardial ischaemia
in all patients. This result might be explained by the fact that a
detailed history was collected before considering AF catheter abla-
tion in order to exclude all possible secondary causes of AF as well
as relevant co-morbidities. Also, coronary CT imaging is infeasible
in patients who are not in sinus rhythm.
Regarding the secondary end-point of our study, incidental find-
ings on the preliminary chest CT scan led us to postpone AF abla-
tion during the same hospital stay in 10 patients and convinced us
not to go ahead with the procedure in 8 patients. We should also
remark that in no patient CT found intra-atrial thrombosis (a clear
indication to postpone ablation), as it was reasonably expected
considering that all patients underwent a preliminary transoeso-
phageal echocardiogram to rule out the presence of thrombi in
the LA or LAA before CT scanning. Even if transoesophageal echo-
cardiogram may be considered not strictly necessary in patients
undergoing cardiac CT scanning, it should be stressed that
Figure 3 The multi-planar imaging (A and B) showed a liver focal enhancement (size 5 mm) suspected for angioma (yellow arrow) in segment
4 of the right lobe. The focal lesion was later evaluated with ultrasound, confirming the nature and the localization of the lesion.
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studies comparing these two techniques are not conclusive and
that transoesophageal echocardiogram is nowadays a robust gold
standard which, at the moment, cannot be replaced by CT scan.26
On the other hand, CT scan is universally considered the gold
standard for the visualization of adjacent intra-thoracic structures
and vessels7 and the incidental detection of subclinical organ
disease is, as mentioned above, a growing issue.8– 15,22 In the
work of Lacomis et al.7 a direct comparison of CT and MRI for
characterization of the posterior LA wall suggested that the tech-
niques provided comparable image quality and information but,
notably, a suspect pulmonary nodule was identified only by CT
scan. Magnetic resonance imaging equipment is surely less widely
available than CT equipment, even when considering the most
recent CT technology, and MRI is sometimes poorly tolerated
by patients, primarily due to the duration and confinement associ-
ated with the exam.
One last consideration regarding the likelihood of collateral find-
ings needs to be discussed. When engaging a diagnostic work-up,
the risk of unwanted effects carried by each procedure must be
taken into account. In this particular case, contrast
medium-induced complications (immune-mediated reactions,
contrast-induced nephropathy), as well as the lifetime attributable
risk of cancer related to exposure to ionizing radiation, represent
the main counterpart of diagnosing otherwise unrecognized con-
ditions. For that reason, a risk/benefit analysis on a large popu-
lation, which takes into account the amount of follow-up
examinations required for patients with clinically significant collat-
eral findings, would be worthwhile.
Limitations
We recognize that our study has some obvious limitations. First,
the duration of clinical follow-up was relatively short at 17+ 5
months. As the standard approach to make certain that a
low-risk pulmonary nodule is benign is to follow it up to demon-
strate stability over at least 2 years, a shorter follow-up time
might have led us to underestimate the significance of such extra-
cardiac findings. Also, prognostic significance has only been deter-
mined indirectly by considering the advantage of an early diagnosis
of lung cancer, since the long-time mortality and adverse event rate
have not been investigated.
Secondly, technical limitations might have prevented visualiza-
tion of some clinically relevant collateral findings. For example,
because the FOV extended from the diaphragmatic domes to
the carina, the pulmonary apexes were left out.
We also recognize that a cost/efficacy analysis was not per-
formed in the present study.
Conclusions
The use of chest CT for image integration in AF ablation may act as
a screening tool for otherwise unrecognized clinically significant
conditions of the heart, lungs, and other visualized organs. These
collateral findings may provide important and potentially decisive
information for the clinical management of patients and their sur-
vival. For this reason, reading radiologists should interpret chest
CT scans for image integration in AF ablation extensively, rather
than just in reference to the electrophysiological procedure, as
this may avoid delays in the diagnosis and treatment of potentially
curable life-threatening diseases.
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